CRVS ($CRVS) Insider Trading & Smart Money Activity

CRVS · Biotechnology · Latest filing Jun 11, 2026

$CRVS has 2 insider trades on file. In the last 12 months on the open market, 1 insider bought ($250.20K) and no insider sold, net +$250.20K.

Insider buyers (12 mo)
1
Insider sellers (12 mo)
0
Net insider $ (12 mo)
+$250.20K
Congress trades (12 mo)
0
13F moves on file
0
Analyst ratings on file
0

CRVS insider buying and selling by quarter

QuarterInsider buysInsider salesCongress buys / sales13F added / cut
Q1 2026 0 0 0 / 0 0 / 0
Q2 2026 1 · $250.20K 0 0 / 0 0 / 0
Q3 2026 0 0 0 / 0 0 / 0
Q4 2026 0 0 0 / 0 0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All CRVS insider, congress, 13F and analyst activity

DateSourceWhoActionSharesValue / amount ΔOwn1W1M6MFilingStory
Insider Peter Thompson Buy (Grant or award) 15K sh +2.7%+26.8% Read
Insider Moore David Scott Buy (Open-market buy) 21.70K sh $250.20K +2.7%+26.8% Read

1W / 1M / 6M = how CRVS moved from the trade or filing date.

Insider trading in CRVS: who is buying and selling

InsiderRoleTradesOpen-market netShares heldLast trade
Peter Thompson 1 — Jun 11, 2026
Moore David Scott 1 +$250.20K Jun 11, 2026

Frequently asked questions

Are CRVS insiders buying or selling?

Over the last 12 months 1 insider made 1 open-market purchase worth $250.20K and 0 insiders made 0 open-market sales worth $0, a net +$250.20K.

What is the latest insider trade in CRVS?

Peter Thompson filed a buy (grant or award) of 15K sh on Jun 11, 2026.

Other biotechnology stocks

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text